Cited by 163Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and MyoclonusAutophagy in Disease and Therapy

The DOI matches its Crossref record; 139 of the 141 references it cites were found in a registry or an index.

Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders

Open access

Plotegher, Nicoletta, Duchen, Michael R.·2017·Trends in Molecular Medicine

DOI 10.1016/j.molmed.2016.12.003

Open this paper in CoChat — free account Open PDF

Abstract

Lysosomal storage disorders (LSDs) are rare inherited debilitating and often fatal disorders. Caused by mutations affecting lysosomal proteins, LSDs are characterized by the accumulation of undegraded material in lysosomes and by lysosomal dysfunction. Although LSDs are multisystemic diseases, the majority display neurologic symptoms and neurodegeneration. Only recently has a role emerged for mitochondrial dysfunction in the pathophysiology of LSDs, suggesting an impact of lysosomal dysfunction on mitochondria. Moreover, mitochondrial damage may also cause lysosomal dysfunction, further supporting the activity of common signaling pathways and crosstalk between the two organelles. In this review we explore the mechanisms linking lysosomal and mitochondrial dysfunction to assess whether specific mitochondrial pathways represent a new therapeutic frontier in the management of LSDs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.molmed.2016.12.003

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Two Pore Channel 2 (TPC2) Inhibits Autophagosomal-Lysosomal Fusion by Alkalinizing Lysosomal pH
Lü, Y., Hao, B., Graeff, R. M., Wong, C. W. M., Wu, W.-T., & Yue, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.484253 · Cited by 92
Retracted
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
TFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D.-F., Gautier, C. A., Shen, J., Cookson, M. R., & Youle, R. J. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000298 · Cited by 2,944
A Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543
Prevalence of lysosomal storage disorders
Meikle, P. J. (1999) · JAMA · doi:10.1001/jama.281.3.249 · Cited by 2,197
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter
Stefani, D. D., Raffaello, A., Teardo, E., Szabó, I., & Rizzuto, R. (2011) · Nature · doi:10.1038/nature10230 · Cited by 1,957
A lysosome‐to‐nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
Settembre, C., Zoncu, R., Medina, D. L., Vetrini, F., Erdin, S., Erdin, S., Huynh, T., Ferron, M., Karsenty, G., Vellard, M. C., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.32 · Cited by 1,920

Show all 141 references

Sorted by citations

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Mitochondria–lysosome contacts regulate mitochondrial fission via RAB7 GTP hydrolysis
Wong, Y. C., Ysselstein, D., & Krainc, D. (2018) · Nature · doi:10.1038/nature25486 · Cited by 911
Lysosomes as a therapeutic target
Bonam, S. R., Wang, F., & Muller, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0036-1 · Cited by 786
Role of lysosomes in physiological activities, diseases, and therapy
Zhang, Z., Yue, P., Lu, T., Wang, Y., Wei, Y., & Wei, X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01087-1 · Cited by 375
Regulation and Function of Mitochondria–Lysosome Membrane Contact Sites in Cellular Homeostasis
Wong, Y. C., Kim, S., Peng, W., & Krainc, D. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.02.004 · Cited by 355
Mitochondria-lysosome contacts regulate mitochondrial Ca 2+ dynamics via lysosomal TRPML1
Peng, W., Wong, Y. C., & Krainc, D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003236117 · Cited by 347
Mitochondria–Lysosome Crosstalk: From Physiology to Neurodegeneration
Deus, C. M., Yambire, K. F., Oliveira, P. J., & Raimundo, N. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.10.009 · Cited by 299
Emerging Roles for the Lysosome in Lipid Metabolism
Thelen, A. M., & Zoncu, R. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.07.006 · Cited by 275
Mannose ameliorates experimental colitis by protecting intestinal barrier integrity
Dong, L., Xie, J., Wang, Y., Jiang, H., Chen, K., Li, D., Wang, J., Liu, Y., He, J., Zhou, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32505-8 · Cited by 267
Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis
Root, J. T., Merino, P., Nuckols, A., Johnson, M. A., & Kukar, T. L. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105360 · Cited by 243
Mitocellular communication: Shaping health and disease
Mottis, A., Herzig, S., & Auwerx, J. H. (2019) · Science · doi:10.1126/science.aax3768 · Cited by 241
The rapidly evolving view of lysosomal storage diseases
Parenti, G., Medina, D. L., & Ballabio, A. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012836 · Cited by 230
Glycoprotein NMB: a novel Alzheimer’s disease associated marker expressed in a subset of activated microglia
Hüttenrauch, M., Ogorek, I., Klafki, H., Otto, M., Stadelmann, C., Weggen, S., Wiltfang, J., & Wirths, O. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0612-3 · Cited by 166
Mechanisms of Regulated Cell Death: Current Perspectives
Santagostino, S. F., Assenmacher, C., Tarrant, J. C., Adedeji, A. O., & Radaelli, E. (2021) · Veterinary Pathology · doi:10.1177/03009858211005537 · Cited by 137
Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration
Audano, M., Schneider, A., & Mitro, N. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14471 · Cited by 118
Pathogenesis of Mucopolysaccharidoses, an Update
Fecarotta, S., Tarallo, A., Damiano, C., Minopoli, N., & Parenti, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072515 · Cited by 128
Mechanisms of Mitochondrial Dysfunction in Lysosomal Storage Disorders: A Review
Stępień, K. M., Roncaroli, F., Turton, N., Hendriksz, C. J., Roberts, M., Heaton, R. A., & Hargreaves, I. P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082596 · Cited by 108
Crosstalk between Lysosomes and Mitochondria in Parkinson's Disease
Plotegher, N., & Duchen, M. R. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00110 · Cited by 106
Self-citation
N-acetylcysteine Pharmacology and Applications in Rare Diseases—Repurposing an Old Antioxidant
Sahasrabudhe, S. A., Terluk, M. R., & Kartha, R. V. (2023) · Antioxidants · doi:10.3390/antiox12071316 · Cited by 102
Mitochondrial biogenesis is transcriptionally repressed in lysosomal lipid storage diseases
Yambire, K. F., Fernández-Mosquera, L., Steinfeld, R., Mühle, C., Ikonen, E., Milošević, I., & Raimundo, N. (2019) · eLife · doi:10.7554/elife.39598 · Cited by 91
Mitochondrial stress management: a dynamic journey
Valera‐Alberni, M., & Cantó, C. (2018) · Cell Stress · doi:10.15698/cst2018.10.158 · Cited by 99
Lysosomal and Mitochondrial Liaisons in Niemann-Pick Disease
Torres, S., Balboa, E., Zanlungo, S., Enrich, C., García‐Ruiz, C., & Fernández-Checa, J. C. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00982 · Cited by 88
Lysosomal Stress Response (LSR): Physiological Importance and Pathological Relevance
Lakpa, K. L., Khan, N., Afghah, Z., Chen, X., & Geiger, J. D. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-09990-7 · Cited by 81
VPS13A, a closely associated mitochondrial protein, is required for efficient lysosomal degradation
Muñoz‐Braceras, S., Tornero-Écija, A., Vincent, O., & Escalante, R. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.036681 · Cited by 87
Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases
Ivanova, M. M., Changsila, E., Iaonou, C., & Göker-Alpan, Ö. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210617 · Cited by 80
Spatiotemporally mapping temperature dynamics of lysosomes and mitochondria using cascade organelle-targeting upconversion nanoparticles
Di, X., Wang, D., Su, Q. P., Liu, Y., Liao, J., Maddahfar, M., Zhou, J., & Jin, D. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2207402119 · Cited by 77
Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson’s disease pathogenesis
Smolders, S., & Broeckhoven, C. V. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00935-4 · Cited by 72
Lysosomal activity regulates Caenorhabditis elegans mitochondrial dynamics through vitamin B12 metabolism
Wei, W., & Ruvkun, G. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008021117 · Cited by 56
Sphingolipid lysosomal storage diseases: from bench to bedside
Rabbo, M. A., Khodour, Y., Kaguni, L. S., & Stiban, J. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01466-0 · Cited by 66
Linking mitochondrial dysfunction to neurodegeneration in lysosomal storage diseases
Saffari, A., Kölker, S., Hoffmann, G. F., & Ebrahimi‐Fakhari, D. (2017) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-017-0048-0 · Cited by 62
Mitochondrial translation deficiency impairs NAD+‐mediated lysosomal acidification
Yagi, M., Toshima, T., Amamoto, R., Do, Y., Hirai, H., Setoyama, D., Kang, D., & Uchiumi, T. (2021) · The EMBO Journal · doi:10.15252/embj.2020105268 · Cited by 58
Low doses of the organic insecticide spinosad trigger lysosomal defects, elevated ROS, lipid dysregulation, and neurodegeneration in flies
Martelli, F., Hernandes, N. H., Zuo, Z., Wang, J., Wong, C.-O., Karagas, N. E., Roessner, U., Rupasinghe, T., Robin, C., Venkatachalam, K., et al. (2022) · eLife · doi:10.7554/elife.73812 · Cited by 59
Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson’s Disease
Sironi, L., Restelli, L. M., Tolnay, M., Neutzner, A., & Frank, S. (2020) · Cells · doi:10.3390/cells9010233 · Cited by 56
Constitutive activation of the PI3K-Akt-mTORC1 pathway sustains the m.3243 A > G mtDNA mutation
Chung, C.-Y., Singh, K., Kotiadis, V. N., Valdebenito, G. E., Ahn, J. H., Topley, E., Tan, J., Andrews, W. D., Bilanges, B., Pitceathly, R. D. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26746-2 · Cited by 55
Self-citation
Mitochondria in Developmental and Adult Neurogenesis
Arrázola, M. S., Andraini, T., Szelechowski, M., Moulédous, L., Pelloquin, L., Davezac, N., Belenguer, P., Rampon, C., & Miquel, M. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9942-y · Cited by 57
Mitochondrial adventures at the organelle society
Diogo, C. V., Yambire, K. F., Fernández-Mosquera, L., Fonseca, T. B., & Raimundo, N. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.124 · Cited by 55
Changes in cellular processes occurring in mucopolysaccharidoses as underestimated pathomechanisms of these diseases
Gaffke, L., Pierzynowska, K., Podlacha, M., Brokowska, J., & Węgrzyn, G. (2019) · Cell Biology International · doi:10.1002/cbin.11275 · Cited by 55
Lysosome-Mitochondrial Crosstalk in Cellular Stress and Disease
Kiraly, S., Stanley, J., & Eden, E. R. (2025) · Antioxidants · doi:10.3390/antiox14020125 · Cited by 58
A zebrafish screen reveals Renin-angiotensin system inhibitors as neuroprotective via mitochondrial restoration in dopamine neurons
Kim, G. J., Mo, H., Liu, H., Wu, Z., Chen, S., Zheng, J., Zhao, X., Nucum, D., Shortland, J., Peng, L., et al. (2021) · eLife · doi:10.7554/elife.69795 · Cited by 49
Targeted Metabolomic Analysis of a Mucopolysaccharidosis IIIB Mouse Model Reveals an Imbalance of Branched-Chain Amino Acid and Fatty Acid Metabolism
Pasquale, V. D., Caterino, M., Costanzo, M., Fedele, R., Ruoppolo, M., & Pavone, L. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124211 · Cited by 49
Altered Sphingolipids Metabolism Damaged Mitochondrial Functions: Lessons Learned From Gaucher and Fabry Diseases
Ivanova, M. M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041116 · Cited by 48
Caspase-8 Induces Lysosome-Associated Cell Death in Cancer Cells
Zhong, B., Liu, M., Bai, C., Ruan, Y., Wang, Y., Qiu, L., Hong, Y., Wang, X., Li, L., & Li, B. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.01.022 · Cited by 48
Targetable Pathways for Alleviating Mitochondrial Dysfunction in Neurodegeneration of Metabolic and Non-Metabolic Diseases
Millichap, L. E., Damiani, E., Tiano, L., & Hargreaves, I. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111444 · Cited by 48
Lysosomal positioning diseases: beyond substrate storage
Scerra, G., Pasquale, V. D., Scarcella, M., Caporaso, M. G., Pavone, L. M., & D'Agostino, M. (2022) · Open Biology · doi:10.1098/rsob.220155 · Cited by 44
Key Mechanisms in Lysosome Stability, Degradation and Repair
Zhang, R., Vooijs, M., & Keulers, T. G. (2025) · Molecular and Cellular Biology · doi:10.1080/10985549.2025.2494762 · Cited by 48
An Alzheimer's Disease-Linked Loss-of-Function CLN5 Variant Impairs Cathepsin D Maturation, Consistent with a Retromer Trafficking Defect
Qureshi, Y. H., Patel, V. M., Berman, D. E., Kothiya, M., Neufeld, J. L., Vardarajan, B. N., Tang, M., Reyes‐Dumeyer, D., Lantigua, R., Medrano, M. Z., et al. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00011-18 · Cited by 46
Accumulation of APP C-terminal fragments causes endolysosomal dysfunction through the dysregulation of late endosome to lysosome-ER contact sites
Bretou, M., Sannerud, R., Escamilla‐Ayala, A., Leroy, T., Vrancx, C., Acker, Z. P. V., Perdok, A., Vermeire, W., Vorsters, I., Keymolen, S. V., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.03.030 · Cited by 47
Impaired cellular bioenergetics caused by GBA1 depletion sensitizes neurons to calcium overload
Plotegher, N., Perocheau, D. P. B., Ferrazza, R., Massaro, G., Bhosale, G., Zambon, F., Rahim, A. A., Guella, G., Waddington, S. N., Szabadkai, G., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0442-2 · Cited by 41
Self-citation
Mitochondrial interaction with the endosomal compartment in endocytosis and mitochondrial transfer
Todkar, K. J., Chikhi, L., & Germain, M. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.05.003 · Cited by 46
Impact of atypical mitochondrial cyclic-AMP level in nephropathic cystinosis
Bellomo, F., Signorile, A., Tamma, G., Ranieri, M., Emma, F., & Rasmo, D. D. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2800-5 · Cited by 40
Clinical Trials for Gene Therapy in Lysosomal Diseases With CNS Involvement
Sevin, C., & Deiva, K. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.624988 · Cited by 39
Aminochrome Induces Irreversible Mitochondrial Dysfunction by Inducing Autophagy Dysfunction in Parkinson's Disease
Segura‐Aguilar, J., & Huenchuguala, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00106 · Cited by 38
A SPLICS reporter reveals $${{{{{\boldsymbol{\alpha }}}}}}$$-synuclein regulation of lysosome-mitochondria contacts which affects TFEB nuclear translocation
Giamogante, F., Barazzuol, L., Maiorca, F., Poggio, E., Esposito, A., Masato, A., Napolitano, G., Vagnoni, A., Calí, T., & Brini, M. (2024) · Nature Communications · doi:10.1038/s41467-024-46007-2 · Cited by 37
Nicotinamide Riboside and Metformin Ameliorate Mitophagy Defect in Induced Pluripotent Stem Cell-Derived Astrocytes With POLG Mutations
Chen, A., Kristiansen, C. K., Hong, Y., Kianian, A., Fang, E. F., Sullivan, G. J., Wang, J., Li, X., Bindoff, L. A., & Liang, K. X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.737304 · Cited by 36
Linking Lysosomal Enzyme Targeting Genes and Energy Metabolism with Altered Gray Matter Volume in Children with Persistent Stuttering
Chow, H. M., Garnett, E. O., Li, H., Etchell, A. C., Sepulcre, J., Drayna, D. T., Chugani, D. C., & Chang, S. (2020) · Neurobiology of Language · doi:10.1162/nol_a_00017 · Cited by 38
Inflammation in Fabry disease: stages, molecular pathways, and therapeutic implications
Kurdi, H., Lavalle, L., Moon, J., & Hughes, D. A. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1420067 · Cited by 38
Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model
Salvalaio, M., D’Avanzo, F., Rigon, L., Zanetti, A., D’Angelo, M., Valle, G., Scarpa, M., & Tomanin, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051072 · Cited by 37
Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson’s Disease
Blumenreich, S., Barav, O. B., Jenkins, B., & Futerman, A. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144966 · Cited by 32
Inhibition of the PI3K-AKT-MTORC1 axis reduces the burden of the m.3243A>G mtDNA mutation by promoting mitophagy and improving mitochondrial function
Chung, C.-Y., Singh, K., Sheshadri, P., Valdebenito, G. E., Chacko, A. R., Costa-Besada, M. A., Liang, X. F., Kabir, L., Pitceathly, R. D. S., Szabadkai, G., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2437908 · Cited by 33
Self-citation
Perspectives on Organelle Interaction, Protein Dysregulation, and Cancer Disease
Díaz, P., Sandoval, A., Bravo, R., Quest, A. F. G., & Lavandero, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.613336 · Cited by 31
Fabry Disease: Cardiac Implications and Molecular Mechanisms
Weissman, D., Dudek, J., Sequeira, V., & Maack, C. (2024) · Current Heart Failure Reports · doi:10.1007/s11897-024-00645-1 · Cited by 31
Fundamentals of CNS energy metabolism and alterations in lysosomal storage diseases
McKenna, M. C., Schuck, P. F., & Ferreira, G. C. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14577 · Cited by 31
Finding pathogenic commonalities between Niemann-Pick type C and other lysosomal storage disorders: Opportunities for shared therapeutic interventions
Yañez, M. J., Marín, T., Balboa, E., Klein, A. D., Alvarez, A. R., & Zanlungo, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165875 · Cited by 30
Regulation of autophagy by perilysosomal calcium: a new player in β-cell lipotoxicity
Nguyen, H. T., Wiederkehr, A., Wollheim, C. B., & Park, K. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01161-x · Cited by 24
Rescue of Advanced Pompe Disease in Mice with Hepatic Expression of Secretable Acid α-Glucosidase
Cagin, U., Puzzo, F., Gómez, M. J., Moya‐Nilges, M., Sellier, P., Abad, C., van Wittenberghe, L., Danièle, N., Guerchet, N., Gjata, B., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.05.025 · Cited by 25
Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
Bertoldi, G., Caputo, I., Driussi, G., Stefanelli, L. F., Vico, V. D., Carraro, G., Nalesso, F., & Calò, L. A. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12052063 · Cited by 25
Celecoxib promotes survival and upregulates the expression of neuroprotective marker genes in two different in vitro models of Parkinson's disease
Dassati, S., Schweigreiter, R., Buechner, S., & Waldner, A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108378 · Cited by 22
Potential Treatment of Lysosomal Storage Disease through Modulation of the Mitochondrial—Lysosomal Axis
Kuk, M. U., Lee, Y. H., Kim, J., Hwang, S. Y., Park, J. T., & Park, S. C. (2021) · Cells · doi:10.3390/cells10020420 · Cited by 22
Antitumoral effects of [6]-gingerol [(S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone] in sarcoma 180 cells through cytogenetic mechanisms
de Lima, R. M. T., dos Reis, A. C., Santos, J. V. D. O., Ferreira, J. R. D. O., Filho, J. W. G. D. O., Dias, A. C. S., de Menezes, A. P. M., da Mata, A. M. O. F., de Alencar, M. V. O. B., Andrade, T. D. J. A. D. S., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110004 · Cited by 25
Pathogenic Roles of Heparan Sulfate and Its Use as a Biomarker in Mucopolysaccharidoses
Minami, K., Morimoto, H., Morioka, H., Imakiire, A., Kinoshita, M., Yamamoto, R., Hirato, T., & Sonoda, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911724 · Cited by 19
When friendship turns sour: Effective communication between mitochondria and intracellular organelles in parkinson’s disease
Lin, T.-K., Lin, K.-J., Lin, K.-L., Liou, C.-W., Chen, S.-D., Chuang, Y.-C., Wang, P.-W., Chuang, J.-H., & Wang, T.-J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.607392 · Cited by 19
Secondary Mitochondrial Dysfunction as a Cause of Neurodegenerative Dysfunction in Lysosomal Storage Diseases and an Overview of Potential Therapies
Stępień, K. M., Cufflin, N., Donald, A., Jones, S. A., Church, H. J., & Hargreaves, I. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810573 · Cited by 19
Proteomic analysis unveils Gb3-independent alterations and mitochondrial dysfunction in a gla−/− zebrafish model of Fabry disease
Elsaid, H. O. A., Rivedal, M., Skandalou, E., Svarstad, E., Tøndel, C., Birkeland, E., Eikrem, Ø., Bábíčková, J., Marti, H., & Furriol, J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04475-y · Cited by 19
Autophagic flux defect in diabetic kidney disease results in megamitochondria formation in podocytes
Woo, C.-Y., Kc, R., Kim, M., Kim, H. S., Baek, J. Y., & Koh, E. H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.10.132 · Cited by 19
TMEM97 ablation aggravates oxidant-induced retinal degeneration
Shen, H., Li, J., Heisler-Taylor, T., Makin, R., Yang, H., Mavlyutov, T. A., Gelfand, B., Cebulla, C. M., & Guo, L.-W. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110078 · Cited by 19
Epigenetic and 3D genome reprogramming during the aging of the human hippocampus
Zemke, N. R., Lee, S. Y., Mamde, S., Yang, B., Berchtold, N. C., Garduño, B. M., Indralingam, H. S., Bartosik, W. M., Lau, P. K., Dong, K., et al. (2026) · Science · doi:10.1126/science.adt8307 · Cited by 32
Cell death classification: A new insight based on molecular mechanisms
Dehghan, S., Kheshtchin, N., Hassannezhad, S., & Soleimani, M. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113860 · Cited by 21
Fabry Disease: Insights into Pathophysiology and Novel Therapeutic Strategies
Thompson, S., Roy, A., Geberhiwot, T., Gehmlich, K., & Steeds, R. P. (2025) · Biomedicines · doi:10.3390/biomedicines13030624 · Cited by 19
The Deficiency of SCARB2/LIMP-2 Impairs Metabolism via Disrupted mTORC1-Dependent Mitochondrial OXPHOS
Zou, Y., Pei, J., Wang, Y., Chen, Q., Sun, M., Kang, L., Zhang, X., Zhang, L., Gao, X., & Lin, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158634 · Cited by 15
Controlled Sequential Assembly of DNA Nanoparticles Inside Cells Enabling Mitochondrial Interference
Yuan, M., Dong, Y., Lv, Z., Liu, J., Liu, M., Xu, M., Guo, X., Yao, C., & Yang, D. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202312880 · Cited by 15
Mitochondrial dysfunction is associated with hypertrophic cardiomyopathy in Pompe disease‐specific induced pluripotent stem cell‐derived cardiomyocytes
Huang, W., Zhou, R., Jiang, C., Wang, J., Zhou, Y., Xu, X., Wang, T., Li, A., & Zhang, Y. (2023) · Cell Proliferation · doi:10.1111/cpr.13573 · Cited by 14
Inflammatory response and its relation to sphingolipid metabolism proteins: Chaperones as potential indirect anti-inflammatory agents
Yagci, Z. B., Esvap, E., Özkara, H. A., Ülgen, K. Ö., & Özkırımlı, E. (2018) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2018.09.004 · Cited by 15
Fabry Disease Beyond Storage: The Role of Inflammation in Disease Progression
Biddeci, G., Spinelli, G., Colomba, P., Duro, G., Giacalone, I., & Blasi, F. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157054 · Cited by 13
Association Between Gray Matter Volume Variations and Energy Utilization in the Brain: Implications for Developmental Stuttering
Boley, N., Patil, S., Garnett, E. O., Li, H., Chugani, D. C., Chang, S., & Chow, H. M. (2021) · Journal of Speech Language and Hearing Research · doi:10.1044/2020_jslhr-20-00325 · Cited by 13
Bu-Yin-Qian-Zheng Formula Ameliorates MPP+-Induced Mitochondrial Dysfunction in Parkinson’s Disease via Parkin
Ma, H., Gai, C., Chai, Y., Feng, W.-D., Cheng, C., Zhang, J., Zhang, Y., Yang, L., Guo, Z., Gao, Y.-S., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.577017 · Cited by 10
Organelle dysfunction and its contribution to metabolic impairments in aging and age-related diseases
Heiby, J. C., & Ori‬‬, A. (2022) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2022.100416 · Cited by 11
Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [18F]BCPP-EF PET study
Shatalina, E., Whitehurst, T., Onwordi, E. C., Gilbert, B. J., Rizzo, G., Whittington, A., Mansur, A., Tsukada, H., Marques, T. R., Natesan, S., et al. (2024) · EJNMMI Research · doi:10.1186/s13550-024-01099-1 · Cited by 10
F-ATP synthase inhibitory factor 1 and mitochondria-organelle interactions: New insight and implications
Guo, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107393 · Cited by 13
sPLA2-IIA modifies progranulin deficiency phenotypes in mouse models
Yang, C., Du, H., Lee, G. B., Uematsu, M., He, W., Doré, É., Yu, W., Sanford, E. J., Smolka, M. B., Boilard, É., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00863-8 · Cited by 10
β-Mannosidosis in German Shepherd Dogs
Jolly, R. D., Dittmer, K. E., Garrick, D. J., Chernyavtseva, A., Hemsley, K. M., King, B. M., Fietz, M., Shackleton, N. M., Fairley, R. A., & Wylie, K. (2019) · Veterinary Pathology · doi:10.1177/0300985819839239 · Cited by 10
Learning Nanoscale Motion Patterns of Vesicles in Living Cells
Sekh, A. A., Opstad, I. S., Birgisdottir, Å. B., Myrmel, T., Ahluwalia, B. S., Agarwal, K., & Prasad, D. K. (2020) · IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings - IEEE Computer Society Conference on Computer Vision and Pattern Recognition/Proceedings · doi:10.1109/cvpr42600.2020.01403 · Cited by 10
Evolving therapies in neuronopathic LSDs: opportunities and challenges
Rajan, D. S., & Escolar, M. L. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00939-0 · Cited by 10
Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progression
Monceau, A., Gokul-Nath, R., Suárez‐Calvet, X., Musumeci, O., Toscano, A., Kierdaszuk, B., Kostera‐Pruszczyk, A., Domínguez‐González, C., Hernández‐Laín, A., Paradas, C., et al. (2024) · Brain · doi:10.1093/brain/awae249 · Cited by 9
4-Phenylbutyric acid mitigates ER stress-induced neurodegeneration in the spinal cords of a GM2 gangliosidosis mouse model
Weaver, F. E., White, E., Peek, A. M. A., Nurse, C. A., Austin, R. C., & Igdoura, S. A. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae153 · Cited by 9
Methylmercury induces lysosomal membrane permeabilization through JNK-activated Bax lysosomal translocation in neuronal cells
Lin, T., Huang, D., Chen, X., Xiaojing, M., Fei, Z., & Bin, W. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2021.12.021 · Cited by 9
Mitochondrial respiratory chain regulates HBV clearance through dual modulation of lysosomal acidification
Wei, Z., Yan, Y., Zhao, L., Li, C., Qi, J., Chen, D., Huang, X., Li, M., Xiao, Z., Lou, G., et al. (2025) · Emerging Microbes & Infections · doi:10.1080/22221751.2025.2563079 · Cited by 8
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Gómez-Cebrián, N., Gras‐Colomer, E., Andrés, J. L. P., Pineda‐Lucena, A., & Puchades‐Carrasco, L. (2023) · Biology · doi:10.3390/biology12091159 · Cited by 8
A genetically modulated Toll-like receptor-tolerant phenotype in peripheral blood cells of children with multisystem inflammatory syndrome
Khan, R., Ji, W., Rivera, J., Madhvi, A., Andrews, T., Richlin, B., Suarez, C., Gaur, S., Hasan, U. N., Cuddy, W., et al. (2025) · The Journal of Immunology · doi:10.1093/jimmun/vkaf006 · Cited by 8
Organellomics: AI-driven deep organellar phenotyping reveals novel ALS mechanisms in human neuronsPreprint
Krispin, S., van Zuiden, W., Danino, Y. M., Rudberg, N., Molitor, L., Abarbanel, B., Aviram, G., Wolf, G., Bar, C., Siani, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.31.572110 · Cited by 8
A new perspective on the regulation of glucose and cholesterol transport by mitochondria-lysosome contact sites
Chen, X., Li, C. G., Zhou, X., Zhu, M., Jin, J., & Wang, P. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1431030 · Cited by 7

Authors: Plotegher, N., & Duchen, M. R.
Affiliations: University College London (GB)
Corresponding author: Duchen, Michael R.
ORCID: Plotegher, Nicoletta
Duchen, Michael R.
Venue: Trends in Molecular Medicine
Publisher: Elsevier BV
Published: 2017-02
Volume: 23
Issue: 2
Pages: 116-134
ISSN: 1471-4914 (ISSN-L)
DOI: 10.1016/j.molmed.2016.12.003
OpenAlex: W2575523348
Cited by: 161
References: 141
Citations by year: 2026: 16 · 2025: 18 · 2024: 23 · 2023: 12 · 2022: 13 · 2021: 18 · 2020: 24 · 2019: 16 · 2018: 14 · 2017: 6
FWCI: 2.01
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Molecular Medicine (publishedVersion)
PubMed (publishedVersion)
Padua Research Archive (University of Padova) (submittedVersion, cc-by-nc-nd)
UCL Discovery (University College London) (submittedVersion, cc-by-nc-nd)
Topics: Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords: lysosomal storage disease, mitochondrial dysfunction, neurodegeneration, lysosomal dysfunction, therapeutic target
MeSH terms: Animals, Humans, Lysosomes, Mitochondria, Mutation, Proteins, Lysosomal Storage Diseases, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mitochondrial Dysfunction and Neurodegeneration in Lysosomal Storage Disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks